Victory Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586M Buy
10,168,924
+1,017,713
+11% +$58.4M 0.33% 54
2026
Q1
$555M Buy
9,151,211
+946,795
+12% +$55.2M 0.36% 47
2025
Q4
$443M Buy
8,204,416
+4,144,765
+102% +$199M 0.25% 82
2025
Q3
$183M Buy
4,059,651
+784,566
+24% +$36.6M 0.11% 185
2025
Q2
$152M Sell
3,275,085
-1,587,935
-33% -$77.9M 0.1% 218
2025
Q1
$297M Buy
4,863,020
+1,989,082
+69% +$116M 0.3% 69
2024
Q4
$163M Sell
2,873,938
-91,384
-3% -$5.11M 0.16% 135
2024
Q3
$153M Sell
2,965,322
-816,074
-22% -$38.3M 0.15% 143
2024
Q2
$157M Buy
3,781,396
+185,100
+5% +$8.28M 0.16% 139
2024
Q1
$195M Buy
3,596,296
+916,229
+34% +$46.7M 0.19% 120
2023
Q4
$138M Buy
2,680,067
+604,991
+29% +$31.8M 0.14% 157
2023
Q3
$120M Buy
2,075,076
+456,575
+28% +$28M 0.14% 163
2023
Q2
$104M Sell
1,618,501
-346,728
-18% -$23.3M 0.11% 210
2023
Q1
$136M Sell
1,965,229
-271,862
-12% -$19.2M 0.15% 146
2022
Q4
$161M Sell
2,237,091
-38,343
-2% -$2.89M 0.19% 122
2022
Q3
$162M Buy
2,275,434
+262,761
+13% +$19.1M 0.19% 121
2022
Q2
$155M Buy
2,012,673
+65,750
+3% +$5.01M 0.18% 138
2022
Q1
$147M Buy
1,946,923
+624,610
+47% +$41.9M 0.15% 154
2021
Q4
$82.4M Buy
1,322,313
+22,543
+2% +$1.32M 0.08% 358
2021
Q3
$76.9M Sell
1,299,770
-139,226
-10% -$9.17M 0.08% 380
2021
Q2
$96.2M Sell
1,438,996
-27,624
-2% -$1.8M 0.09% 289
2021
Q1
$92.6M Sell
1,466,620
-307,037
-17% -$19.1M 0.09% 285
2020
Q4
$110M Sell
1,773,657
-1,197,140
-40% -$73.6M 0.12% 225
2020
Q3
$179M Sell
2,970,797
-91,073
-3% -$5.48M 0.23% 94
2020
Q2
$180M Sell
3,061,870
-131,250
-4% -$7.85M 0.24% 84
2020
Q1
$178M Sell
3,193,120
-149,697
-4% -$9.15M 0.3% 62
2019
Q4
$215M Buy
3,342,817
+1,942,071
+139% +$111M 0.26% 79
2019
Q3
$71M Buy
1,400,746
+712,949
+104% +$33.5M 0.09% 315
2019
Q2
$31.2M Buy
687,797
+360,484
+110% +$16.8M 0.06% 455
2019
Q1
$15.6M Buy
327,313
+303,248
+1,260% +$15.1M 0.04% 621
2018
Q4
$1.25M Sell
24,065
-160
-0.7% -$8.6K ﹤0.01% 1155
2018
Q3
$1.5M Sell
24,225
-467
-2% -$27.7K ﹤0.01% 1166
2018
Q2
$1.37M Sell
24,692
-208,340
-89% -$11.3M ﹤0.01% 1175
2018
Q1
$14.7M Sell
233,032
-40,161
-15% -$2.58M 0.03% 656
2017
Q4
$16.7M Sell
273,193
-12,752
-4% -$798K 0.04% 617
2017
Q3
$18.2M Buy
285,945
+139,374
+95% +$8.14M 0.04% 608
2017
Q2
$8.17M Buy
146,571
+50,992
+53% +$2.77M 0.02% 739
2017
Q1
$5.2M Sell
95,579
-392,133
-80% -$21.5M 0.01% 798
2016
Q4
$28.5M Sell
487,712
-449,561
-48% -$24.6M 0.07% 469
2016
Q3
$50.5M Buy
937,273
+579,471
+162% +$37.2M 0.14% 240
2016
Q2
$26.3M Buy
357,802
+34,170
+11% +$2.41M 0.11% 341
2016
Q1
$20.7M Buy
323,632
+301,159
+1,340% +$19M 0.09% 403
2015
Q4
$1.55M Buy
+22,473
New +$1.49M 0.01% 691
2015
Q3
Sell
-11,205
Closed -$755K 1633
2015
Q2
$755K Buy
+11,205
New +$738K ﹤0.01% 870
2015
Q1
Sell
-120
Closed -$7K 876
2014
Q4
$7K Buy
+120
New +$6.77K ﹤0.01% 891
2013
Q4
Sell
-289
Closed -$13K 940
2013
Q3
$13K Buy
+289
New +$12.7K ﹤0.01% 996

Other funds holding BMY

Victory Capital Management's BMY Position: Q2 2026 in Review

Victory Capital Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $58.4M and bringing the position to 10,168,924 shares worth $586M. The position accounts for 0.33% of the portfolio, ranked #54.

Victory Capital Management first reported a position in BMY in Q3 2013 and has held it in 46 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Victory Capital Management held 10,168,924 shares of Bristol-Myers Squibb worth $586M as of Q2 2026.
  • Victory Capital Management bought 1,017,713 Bristol-Myers Squibb shares in Q2 2026, an estimated $58.4M.
  • Bristol-Myers Squibb made up 0.33% of Victory Capital Management's portfolio in Q2 2026, its #54 holding.
  • Victory Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 46 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.